enow.com Web Search

  1. Ad

    related to: latest news on als treatment options

Search results

  1. Results from the WOW.Com Content Network
  2. Experimental treatment pushed by ALS patients gets day ... - AOL

    www.aol.com/news/experimental-treatment-pushed...

    NurOwn is the clearest test yet of how far the agency may be willing to bend to approve a new medicine for a rare and deadly condition with few treatment options. ALS gradually destroys nerve ...

  3. FDA advisers vote against experimental ALS treatment ... - AOL

    www.aol.com/news/fda-advisers-vote-against...

    In the last year, the FDA has approved two new drugs for ALS, after a nearly 20-year drought of new options. The approvals followed intense lobbying by advocacy groups.

  4. ALS drug will be pulled from US market after study showed ...

    www.aol.com/news/als-drug-pulled-us-market...

    The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn't help patients with the deadly ...

  5. Amyotrophic lateral sclerosis research - Wikipedia

    en.wikipedia.org/wiki/Amyotrophic_lateral...

    Familial ALS is the most studied; however, a new technique that was recently introduced is the use of induced pluripotent stem cells (iPSC). [2] In this study the researcher can isolate skin fibroblast from a patient with familial or sporadic ALS and reprogram them into motor neuron to study ALS. [ 2 ]

  6. ALS Therapy Development Institute - Wikipedia

    en.wikipedia.org/wiki/ALS_Therapy_Development...

    The institute has raised and spent more than $100 million on research into effective treatments for ALS and practices open-source science. [19] After the discovery that the multiple sclerosis drug Gilenya might also be a treatment for ALS, the Institute enrolled 30 people in a Phase 2A clinical trial the drug in 2013, though it did not progress further.

  7. Tofersen - Wikipedia

    en.wikipedia.org/wiki/Tofersen

    Tofersen was developed by Ionis Pharmaceuticals and was licensed to, and co-developed by, Biogen. [7] [8]The effectiveness of tofersen was evaluated in a 28-week, randomized, double-blind, placebo-controlled clinical study in 147 participants with weakness attributable to amyotrophic lateral sclerosis and a superoxide dismutase 1 (SOD-1) mutation confirmed by a central laboratory. [2]

  8. Denali-Sanofi's ALS drug fails to meet mid-stage trial goal - AOL

    www.aol.com/news/denali-sanofis-als-drug-fails...

    Shares of Denali were down nearly 8% in morning trading. This marks the latest setback in the long list of roadblocks in the path to develop effective treatments against amyotrophic lateral ...

  9. ALS Association - Wikipedia

    en.wikipedia.org/wiki/ALS_Association

    The ALS Association is an American nonprofit organization that funds global amyotrophic lateral sclerosis (ALS) research, provides care services and programs to people affected by ALS through its nationwide network of clinical care centers, and works with ALS advocates around the country for state and federal policies that serve people living with amyotrophic lateral sclerosis (ALS), also ...

  1. Ad

    related to: latest news on als treatment options